Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study

A guide to immunotherapy for COVID-19

(2022) Frank L. van de Veerdonk et al.   NATURE MEDICINE

Innate immunological pathways in COVID-19 pathogenesis

(2022) Søren R. Paludan et al.   Science Immunology

COVID-19 ARDS: One Pathogen, Multiple Phenotypes

(2022) Susannah Empson et al.   CRITICAL CARE CLINICS

First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation

(2022) Sébastien Tanaka et al.   Biomedicines

Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and ARDS

(2022) Julian A Villalba et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Altered high-density lipoprotein composition and functions during severe COVID-19

(2021) Floran Begue et al.   Scientific Reports

Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin–Cholesterol Acyltransferase Deficiency

(2021) Stanislas Faguer et al.   ANNALS OF INTERNAL MEDICINE

Association of serum HDL cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection

(2021) James R. Hilser et al.   JOURNAL OF LIPID RESEARCH

Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity

(2021) Kyung-Hyun Cho et al.   Antioxidants

ApoA1 neutralizes pro-inflammatory effects of Dengue virus NS1 protein and modulates the viral immune evasion

(2021) Diego R. Coelho et al.   JOURNAL OF VIROLOGY

Discrimination of COVID‐19 from inflammation‐induced cytokine storm syndromes by disease‐related blood biomarkers

(2021) Christoph Kessel et al.   Arthritis & Rheumatology

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1

(2021) Sabrina Pagano et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

(2021) Takaki Asano et al.   Science Immunology

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

(2021) Raphael Carapito et al.   Science Translational Medicine

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

(2021) Jean-Pierre Gangneux et al.   Lancet Respiratory Medicine

COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches

(2020) Alexander V. Sorokin et al.   FASEB JOURNAL

An inflammatory cytokine signature predicts COVID-19 severity and survival

(2020) Diane Marie Del Valle et al.   NATURE MEDICINE

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

(2020) Thierry Poynard et al.   PLoS One

Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19

(2020) Jia Teng Sun et al.   Frontiers in Cardiovascular Medicine

Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations

(2019) Damariz Marin-Palma et al.   PLoS One

Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial

(2018) Stephen J. Nicholls et al.   JAMA Cardiology

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages

(2010) Lesley E. Smythies et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

(2008) N. Nishimoto et al.   BLOOD